Last reviewed · How we verify

NCT03800303

Integrated Treatment for Youth With Mood Disorders

Completed NA Last updated 29 December 2020
What this trial tests

NA trial testing Family-based treatment in Mood Disorders in Children and Adolescents in 84 participants. Completed in 31 December 2019.

Timeline
15 March 2018
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment84
Start date15 March 2018
Primary completion31 December 2019
Estimated completion31 December 2019
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 10 to 18, any sex, with Mood Disorders in Children and Adolescents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In an effort to understand the effects of evidence-based interventions on children and adolescents, the aims of this study are to: 1. evaluate the feasibility of utilizing wearable devices to track health information (i.e., sleep, physical activity); 2. evaluate the effectiveness of evidence-based intervention components on mood and interpersonal functioning, family engagement, and sleep and physical activity level outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Family-based treatment

Trials testing the same drug.

Other recruiting trials for Mood Disorders in Children and Adolescents

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03800303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing